CIBC Asset Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,729
Closed -$214K 1189
2024
Q1
$214K Buy
+7,729
New +$172K ﹤0.01% 996
2022
Q4
Sell
-8,990
Closed -$217K 1207
2022
Q3
$217K Hold
8,990
﹤0.01% 1052
2022
Q2
$283K Sell
8,990
-213
-2% -$7.72K ﹤0.01% 914
2022
Q1
$405K Hold
9,203
﹤0.01% 902
2021
Q4
$400K Buy
+9,203
New +$361K ﹤0.01% 920
2021
Q3
Sell
-5,456
Closed -$231K 1486
2021
Q2
$231K Hold
5,456
﹤0.01% 1182
2021
Q1
$205K Buy
+5,456
New +$171K ﹤0.01% 1240

Other funds holding ACH

CIBC Asset Management's ACH Position: Q2 2024 in Review

CIBC Asset Management sold out of Accendra Health (ACH) in Q2 2024, closing a stake of 7,729 shares — an estimated $214K sold.

CIBC Asset Management first reported a position in ACH in Q1 2021 and held it in 7 quarters. The position peaked at $405K in Q1 2022. 221 funds tracked by Wall St. Rank hold ACH as of Q2 2024.

  • CIBC Asset Management reported no remaining Accendra Health position as of Q2 2024 after selling out during the quarter.
  • CIBC Asset Management sold 7,729 Accendra Health shares in Q2 2024, an estimated $214K.
  • CIBC Asset Management first reported a position in Accendra Health in Q1 2021 and held it in 7 quarters.
  • CIBC Asset Management's Accendra Health position peaked at $405K in Q1 2022.
  • 221 funds tracked by Wall St. Rank held Accendra Health as of Q2 2024.

Based on CIBC Asset Management's 13F filing for Q2 2024, filed 1 Aug 2024.